These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35954686)

  • 1. Relationship between Doping Prevalence and Socioeconomic Parameters: An Analysis by Sport Categories and World Areas.
    Terreros JL; Manonelles P; López-Plaza D
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisation.
    Lauritzen F; Holden G
    Drug Test Anal; 2023 May; 15(5):506-515. PubMed ID: 36582051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Anti-Doping Rule Violations That Have Impacted Medal Results at the Summer Olympic Games 1968-2012.
    Kolliari-Turner A; Lima G; Hamilton B; Pitsiladis Y; Guppy FM
    Sports Med; 2021 Oct; 51(10):2221-2229. PubMed ID: 33835351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping in Paralympic sport: perceptions, responsibility and anti-doping education experiences from the perspective of Paralympic athletes and parasport coaches.
    Blank C; Weber K; Boardley ID; Abel T; Schobersberger W; Patterson LB
    Front Sports Act Living; 2023; 5():1166139. PubMed ID: 37483282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping in the Ultimate Fighting Championship (UFC): A 4-year epidemiological analysis.
    Fares MY; Baydoun H; Salhab HA; Khachfe HH; Fares Y; Fares J; Abboud JA
    Drug Test Anal; 2021 Apr; 13(4):785-793. PubMed ID: 33270353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreational Athletes' Use of Performance-Enhancing Substances: Results from the First European Randomized Response Technique Survey.
    Christiansen AV; Frenger M; Chirico A; Pitsch W
    Sports Med Open; 2023 Jan; 9(1):1. PubMed ID: 36617340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping practices in international weightlifting: analysis of sanctioned athletes/support personnel from 2008 to 2019 and retesting of samples from the 2008 and 2012 Olympic Games.
    Kolliari-Turner A; Oliver B; Lima G; Mills JP; Wang G; Pitsiladis Y; Guppy FM
    Sports Med Open; 2021 Jan; 7(1):4. PubMed ID: 33415428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The athletic characteristics of Olympic sports to assist anti-doping strategies.
    Hayward G; Gaborini L; Sims D; Schumacher YO; Millet GP; Rhumorbarbe D; Coquet R; Robinson N
    Drug Test Anal; 2022 Sep; 14(9):1599-1613. PubMed ID: 35732071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
    Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of doping control test results in individual and team sports from 2003 to 2015.
    Aguilar-Navarro M; Muñoz-Guerra J; Del Mar Plara M; Del Coso J
    J Sport Health Sci; 2020 Mar; 9(2):160-169. PubMed ID: 32099724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
    Mercado Soberanes K; Camacho Frías E; Rodríguez Balandrán L; Rodríguez Fermán ME; Mendoza Méndez N; Velasco-Bejarano B
    Adicciones; 2019 Jul; 31(3):201-211. PubMed ID: 30059594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
    Al Ghobain M; Konbaz MS; Almassad A; Alsultan A; Al Shubaili M; AlShabanh O
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():14. PubMed ID: 27083557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O; Kuipers H; van Bottenburg M
    Sports Med; 2015 Jan; 45(1):57-69. PubMed ID: 25169441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.